Cite
HARVARD Citation
Bernhard, J. et al. (n.d.). Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. Lancet oncology. 16 (7), pp. 848-858. [Online].